Patent ID: 7153823

Claim:
A method for the administration of a therapeutic amount of a growth factor protein formulation in the treatment of a patient displaying symptoms of acute coronary artery disease comprising the steps of: a) administering by inhalation thereby at least one dose of an effective amount of a first therapeutic growth factor protein formulation comprising: 1. a growth factor protein selected from the group consisting of FGF-1 and FGF-2, and mixtures thereof, and 2. PIGF; b) monitoring one or more clinical indicators of acute coronary artery disease; c) determining, based on monitoring the one or more clinical indicators of coronary artery disease, whether an additional dose of a therapeutic growth factor protein formulation is indicated; d) depending on the results of step c), administering one or more additional doses of a second growth factor protein formulation comprising: 1. a growth factor protein being selected from the group consisting of FGF-1 and FGF-2, and mixtures thereof, and 2. PIGF; and e) repeating steps b) through d) until there is a clinical indication of amelioration of the symptoms of acute coronary artery disease in the patient, or until there is a contraindication to continued treatment.